These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21352913)

  • 1. Drug release mechanisms of cast lipid implants.
    Kreye F; Siepmann F; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):394-400. PubMed ID: 21352913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release mechanisms of compressed lipid implants.
    Kreye F; Siepmann F; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):27-35. PubMed ID: 21055453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release implants based on cast lipid blends.
    Kreye F; Siepmann F; Zimmer A; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Sci; 2011 May; 43(1-2):78-83. PubMed ID: 21463679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
    Güres S; Siepmann F; Siepmann J; Kleinebudde P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms.
    Guse C; Koennings S; Kreye F; Siepmann F; Goepferich A; Siepmann J
    Int J Pharm; 2006 May; 314(2):137-44. PubMed ID: 16503388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cast lipid implants for controlled drug delivery: importance of the tempering conditions.
    Kreye F; Siepmann F; Zimmer A; Willart JF; Descamps M; Siepmann J
    J Pharm Sci; 2011 Aug; 100(8):3471-3481. PubMed ID: 21544819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the experimental conditions on drug release from parenteral depot systems: From negligible to significant.
    Delplace C; Kreye F; Klose D; Danède F; Descamps M; Siepmann J; Siepmann F
    Int J Pharm; 2012 Aug; 432(1-2):11-22. PubMed ID: 22569229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modeling of drug release from lipid dosage forms.
    Siepmann J; Siepmann F
    Int J Pharm; 2011 Oct; 418(1):42-53. PubMed ID: 21802501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implants.
    Herrmann S; Mohl S; Siepmann F; Siepmann J; Winter G
    Pharm Res; 2007 Aug; 24(8):1527-37. PubMed ID: 17380261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of extended release mini-tablets using directly compressible grades of HPMC.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1690-7. PubMed ID: 23078551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mathematical model quantifying drug release from lipid implants.
    Siepmann F; Herrmann S; Winter G; Siepmann J
    J Control Release; 2008 Jun; 128(3):233-40. PubMed ID: 18442866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MALDI-TOF MS imaging of controlled release implants.
    Kreye F; Hamm G; Karrout Y; Legouffe R; Bonnel D; Siepmann F; Siepmann J
    J Control Release; 2012 Jul; 161(1):98-108. PubMed ID: 22551600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic and static curing of ethylcellulose:PVA-PEG graft copolymer film coatings.
    Muschert S; Siepmann F; Leclercq B; Siepmann J
    Eur J Pharm Biopharm; 2011 Aug; 78(3):455-61. PubMed ID: 21349330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug release from MCC- and carrageenan-based pellets: experiment and theory.
    Kranz H; Jürgens K; Pinier M; Siepmann J
    Eur J Pharm Biopharm; 2009 Oct; 73(2):302-9. PubMed ID: 19465119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms controlling protein release from lipidic implants: effects of PEG addition.
    Herrmann S; Winter G; Mohl S; Siepmann F; Siepmann J
    J Control Release; 2007 Apr; 118(2):161-8. PubMed ID: 17275943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico simulation of niacin release from lipid tablets: theoretical predictions and independent experiments.
    Velghe C; Rosiaux Y; Marchaud D; Siepmann J; Siepmann F
    J Control Release; 2014 Feb; 175():63-71. PubMed ID: 24368299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc-pectinate beads as an in vivo self-assembling system for pulsatile drug delivery.
    Dhalleine C; Assifaoui A; Moulari B; Pellequer Y; Cayot P; Lamprecht A; Chambin O
    Int J Pharm; 2011 Jul; 414(1-2):28-34. PubMed ID: 21601627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous controlled vitamin release from multiparticulates: theory and experiment.
    Seidenberger T; Siepmann J; Bley H; Maeder K; Siepmann F
    Int J Pharm; 2011 Jun; 412(1-2):68-76. PubMed ID: 21515349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.